Last update April 6, 2023

Abacavir (ABC) / Lamivudine (3TC)

Compatible

Safe product and/or breastfeeding is the best option.

Abacavir/lamivudine is a fixed-dose combination of two antiretrovirals, both nucleoside reverse transcriptase inhibitors (NRTIs), used to treat HIV/AIDS in combination with other antiretrovirals. Oral administration.

Both abacavir and lamivudine are compatible with lactation.

The commentary and bibliography can be consulted in the abacavir and lamivudine files.

This combination is considered essential medication by the WHO. (WHO 2021)


See below the information of these related products:

Alternatives

We do not have alternatives for Abacavir (ABC) / Lamivudine (3TC) since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Abacavir (ABC) / Lamivudine (3TC) in other languages or writings:

Group

Abacavir (ABC) / Lamivudine (3TC) belongs to this group or family:

Tradenames

Main tradenames from several countries containing Abacavir (ABC) / Lamivudine (3TC) in its composition:

References

  1. WHO. World Health Organization. Model List of Essential Medicines. 22nd List. 2021

Total visits

6,582

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM